MedTrace Logo

European Association of Cardiovascular Imaging Multiple and Mixed Valvular Disease Study

NCT06235385 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1500

Last updated 2024-06-03

No results posted yet for this study

Summary

This study aims to investigate the prevalence and characteristics of multiple and mixed valvular heart disease (MMVD), which includes combinations of stenotic or regurgitant lesions on cardiac valves. The research will be conducted as a multicenter observational study, involving several centers worldwide, and will have a one-year follow-up period (with a possible extension to 5 years). The primary aim is to determine the proportion of MMVD among patients evaluated for valvular heart disease. Secondary aims include the evaluation of the epidemiologic distribution of clinical, biological, and cardiovascular imaging characteristics at baseline, management strategies, and their impact on prognosis. The study will also evaluate clinical outcomes such as mortality, hospitalization for heart failure, and changes in echocardiographic parameters. This research aims to provide valuable insights into the diagnosis, management, and prognosis of MMVD, addressing an important knowledge gap in this area.

Conditions

  • Heart Valve Diseases
  • Multiple Valve Disease, Unspecified
  • Aortic Valve Disease
  • Aortic Valve Stenosis
  • Aortic Valve Insufficiency
  • Mitral Valve Disease
  • Mitral Valve Stenosis
  • Mitral Valve Insufficiency and Aortic Valve Insufficiency
  • Mitral Valve Insufficiency
  • Aortic Valve Stenosis With Insufficiency
  • Mitral Valve Disease Mixed
  • Tricuspid Valve Insufficiency
  • Tricuspid Valve Disease
  • Tricuspid Stenosis

Interventions

OTHER

Intervention not provided

This study is purely observational

Sponsors & Collaborators

  • European Association of Cardiovascular Imaging

    collaborator OTHER

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-07
Primary Completion
2024-08-01
Completion
2029-08-01

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06235385 on ClinicalTrials.gov